David George Lowe Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for David George Lowe.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of David George Lowe. David George Lowe is Director in ARCA biopharma, Inc. ($ABIO) and CEO and President in Aeglea BioTherapeutics, Inc. ($AGLE).
Latest Insider Trading Transactions of David George Lowe
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 22 2017 | AGLE | Aeglea BioTherapeu ... | Lowe David George | CEO and President | Option Exercise | A | 8.03 | 160,000 | 1,284,800 | 160,000 | |
| May 19 2016 | AGLE | Aeglea BioTherapeu ... | Lowe David George | CEO and President | Option Exercise | A | 7.28 | 160,000 | 1,164,800 | 160,000 | |
| Apr 12 2016 | AGLE | Aeglea BioTherapeu ... | Lowe David George | CEO and President | Option Exercise | C | 0.00 | 2,801 | 0 | 0 | |
| Apr 12 2016 | AGLE | Aeglea BioTherapeu ... | Lowe David George | CEO and President | Option Exercise | C | 0.00 | 2,857 | 0 | 0 | |
| Apr 12 2016 | AGLE | Aeglea BioTherapeu ... | Lowe David George | CEO and President | Buy | C | 0.00 | 5,658 | 0 | 5,658 | 0 to 5.7 K |
| Jun 15 2009 | ABIO | ARCA biopharma, In ... | Lowe David George | Director | Sell | S | 3.90 | 6,100 | 23,818 | 335,400 | 341.5 K to 335.4 K (-1.79 %) |
| Jun 15 2009 | ABIO | ARCA biopharma, In ... | Lowe David George | Director | Sell | S | 3.94 | 3,800 | 14,990 | 341,500 | 345.3 K to 341.5 K (-1.10 %) |
| Jun 15 2009 | ABIO | ARCA biopharma, In ... | Lowe David George | Director | Sell | S | 3.84 | 40,700 | 156,479 | 345,300 | 386 K to 345.3 K (-10.54 %) |
| Jun 10 2009 | ABIO | ARCA biopharma, In ... | Lowe David George | Director | Sell | S | 3.96 | 36,000 | 142,448 | 386,000 | 422 K to 386 K (-8.53 %) |
| Jun 10 2009 | ABIO | ARCA biopharma, In ... | Lowe David George | Director | Sell | S | 3.99 | 47,500 | 189,392 | 422,000 | 469.5 K to 422 K (-10.12 %) |
| Jun 10 2009 | ABIO | ARCA biopharma, In ... | Lowe David George | Director | Sell | S | 4.21 | 65,708 | 276,388 | 469,500 | 535.2 K to 469.5 K (-12.28 %) |
| Jun 03 2009 | ABIO | ARCA biopharma, In ... | Lowe David George | Director | Sell | J | 0.00 | 342,375 | 0 | 535,208 | 877.6 K to 535.2 K (-39.01 %) |
| Mar 03 2009 | ABIO | ARCA biopharma, In ... | Lowe David George | Director | Option Exercise | A | 5.29 | 7,500 | 39,675 | 7,500 |
Page: 1